{
    "title": "Novartis signs $50 mln deal for Mesoblast cell therapy for COVID, beyond",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8969321/Novartis-signs-50-mln-deal-Mesoblast-cell-therapy-COVID-beyond.html",
    "date": "2020-11-20",
    "keywords": [
        "therapy",
        "covid19",
        "respiratory",
        "remestemcell",
        "treatment",
        "deal",
        "cell",
        "mesoblast",
        "distress",
        "latestage",
        "novartis",
        "work",
        "drug",
        "john",
        "portfolio",
        "offtheshelf",
        "commercialize",
        "manufacture",
        "syndrome",
        "promise",
        "compassionate",
        "use",
        "programme",
        "march",
        "survival",
        "rate",
        "medicine",
        "hospital",
        "opportunity",
        "experience",
        "developer",
        "tsai",
        "friday",
        "kymriah",
        "cancer",
        "patient",
        "quality",
        "food",
        "administration",
        "trial",
        "reporting",
        "miller",
        "michael"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}